$JPM

JPMorgan, Morgan Stanley Expand Crypto ETF Stakes in Q2 Despite Market Volatility — BigGo Finance

According to JPMorgan Chase & Co. and Morgan Stanley Form 13F filings for holdings as of June 30, both increased stakes in crypto ETFs in Q2. JPMorgan raised IBIT shares to about 10.4M (about $356M) and ETHA to about 1.17M, plus first XRP-related positions. Morgan Stanley also added IBIT and expanded ETH exposure.

Original reporting
Published Aug 14, 2026, 6:22 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 15, 2026, 4:02 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$JPM
Bullish
medium confidence
Mentioned
$JPM · $MS
Relevance
4/10
alphai data visualization · based on finance.biggo.com
Decision brief

The 30-second read

$JPMBullishLow
01

Why it matters

For traders, the main signal is incremental institutional participation in spot-crypto ETF wrappers (IBIT, ETHA) and first-time XRP-related exposure, but the lagged nature of 13F limits immediate trading utility.

02

Market read

The article is a routine but directionally supportive read-through for regulated crypto ETF adoption by major US banks, with limited direct implications for bank equity trading.

03

What to watch

Reported values can fall even when share counts rise due to crypto price moves; 13F also omits short positions, so net exposure could be different.

Relevance 4/10Novelty 4/10Timing: 13F filings reported Wednesday, reflecting positions as of June 30.

Background

The article summarizes Q2 Form 13F filings for JPMorgan and Morgan Stanley, focusing on their holdings in regulated crypto ETFs and XRP-related products.

Company-level read

Ticker impact

$JPMBullishMedium confidence
Context

JPMorgan’s Q2 13F shows a more than fourfold increase in IBIT shares and a fourfold jump in ETHA shares, signaling expanded crypto ETF exposure.

Expected impact

Likely limited near-term impact on JPM equity; any effect is indirect via sentiment around institutional crypto adoption.

Evidence & confidence

The disclosure is a Q2 13F (not a real-time trading catalyst) and 13F aggregates across divisions, so it is informative but not a precise directional bet.

$MSBullishMedium confidence
Context

Morgan Stanley’s Q2 13F increased IBIT share count and more than tripled its position in BlackRock’s Ethereum ETF, despite lower reported value from BTC price declines.

Expected impact

Small, likely sentiment-driven effect on MS; not expected to move the stock materially without additional contemporaneous catalysts.

Evidence & confidence

13F is lagged (holdings as of June 30) and excludes shorts, so it does not cleanly translate into net exposure or near-term trading behavior.

Market effects

Reinforces the trend of large banks using regulated crypto ETFs (BTC, ETH, and some XRP-linked products) rather than direct crypto holdings.

Primarily US-focused institutional sentiment; could marginally influence US-listed crypto ETF complex flows expectations.

Supports a broader global narrative that major financial institutions are normalizing crypto exposure via ETFs.

Counterpoint

13F long positions may reflect client facilitation, inventory, or internal allocations, not a proprietary bullish view on crypto prices.

Key entities

  • JPMorgan Chase & Co.

    Expanded Q2 13F long positions in BlackRock’s iShares Bitcoin Trust (IBIT) and iShares Ethereum Trust (ETHA), plus first-time XRP-related product exposure.

  • Morgan Stanley

    Increased Q2 13F long positions in IBIT and more than tripled its position in BlackRock’s Ethereum ETF, while also disclosing its own Bitcoin trust.

  • BlackRock iShares Bitcoin Trust ETF (IBIT)

    Bitcoin spot ETF referenced in both banks’ Q2 13F share counts.

  • iShares Ethereum Trust ETF (ETHA)

    Ethereum spot ETF referenced in both banks’ Q2 13F share counts.

  • Grayscale XRP product and Bitwise XRP ETF

    XRP-related products where JPMorgan reported initial small Q2 13F positions.

Related articles

$RYMedAI 8/10

Moneris sale to U.S. owner adds risk to Canada’s data sovereignty, payments industry leaders warn

RBC and BMO said they agreed to jointly sell Moneris Solutions Corp. to California-based Francisco Partners for about $2 billion in cash, with each lender taking a 50% share. The deal raises Canadian data sovereignty concerns. Moneris processes over $5 billion in transactions annually across 325,000 commerce points; regulatory approvals are needed, with expected close by end of fiscal Q1 2027.

$METAMed

Futures Erase Overnight Gains As Oil Hits One-Week High, Yen Slides

US equity futures largely gave back overnight gains after oil hit a one-week high and the yen weakened. Traders await US CPI and PPI, with rate-hike bets cooling after Friday’s jobs report. JPMorgan raised its S&P 500 year-end target to 8000. Corporate movers include AAON (+8%), ABCL (+22%), HZO halted on a $53 buyout, and VREX surging on Teledyne’s $18.90 offer.

$JPMMed

Wall Street Giants Are Facing a Reckoning After a New Report Links Their Silence to Epstein’s Ability To Fund His Operations

A Senate Democrats Finance Committee report, cited by NPR, alleges that JPMorgan Chase, Bank of America, and Deutsche Bank knew of suspicious transactions linked to Jeffrey Epstein for years but delayed filing suspicious activity reports. The report cites Treasury documents and bank records, saying Epstein moved over $1 billion. Deutsche Bank and Bank of America deny wrongdoing; JPMorganChase did not comment.

$BXMed

Blackstone pitches $36 billion debt deal for Anthropic AI chips

Blackstone is proposing a $36 billion debt financing for Anthropic to fund use of Google custom AI chips across five data center locations, according to people cited by Bloomberg. The earlier $35 billion structure involved Broadcom, Apollo, and Blackstone via AI XPV Platform, with Broadcom supporting senior tranches. Anthropic has confidentially filed for a US IPO, targeting October, with Morgan Stanley, Goldman Sachs, and JPMorgan involved.